# DEFERASIROX
> **ANDA213146** · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2024-05-03
## Drug
- **FDA Application Number:** ANDA213146
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DEFERASIROX
- **Generic name:** Deferasirox
- **Active ingredients:** DEFERASIROX
- **Dosage form:** GRANULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** PHARMOBEDIENT
- **First approval:** 2024-05-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213146)
---
*AI Analytics · CC0 1.0*